Abstract
Isosorbide dinitrate, which releases nitric oxide in vivo, and prostaglandin E1 synergised in reducing platelet deposition and increasing platelet survival time in patients with peripheral vascular disease.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Arteriosclerosis / blood*
-
Arteriosclerosis / complications
-
Coronary Disease / blood*
-
Coronary Disease / complications
-
Drug Administration Schedule
-
Drug Evaluation
-
Drug Synergism
-
Female
-
Humans
-
Isosorbide Dinitrate / administration & dosage
-
Isosorbide Dinitrate / pharmacology*
-
Male
-
Middle Aged
-
Platelet Aggregation / drug effects*
-
Platelet Aggregation Inhibitors / pharmacology
-
Platelet Count / drug effects*
-
Prostaglandins E / administration & dosage
-
Prostaglandins E / pharmacology*
-
Randomized Controlled Trials as Topic
Substances
-
Platelet Aggregation Inhibitors
-
Prostaglandins E
-
Isosorbide Dinitrate